Vibegron for weight and energy in older adults
Part of Hormones & metabolism clinical trials.
This study tests whether a medication called vibegron can help older adults who are overweight or have obesity improve their energy and thinking. It may also help with weight management, but the main focus is on how it affects daily energy and mental sharpness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with a large waist size (over 102 cm for men, over 88 cm for women).
- Your weight must be under 450 pounds.
- You must not have had major depression, memory problems, or certain brain or nervous system conditions.
- Your diabetes must be well controlled (hemoglobin A1c of 7% or less).
- You must not have had a weight change of 5% or more in the past 6 months.
- You must not have had weight-loss surgery or be taking certain weight-loss or heart medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental pill that may help people with overweight or obesity lose weight. It compares the pill alone or with another medication to see if it is safe and works well.
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
This study tests a new medicine to see how it affects the body's energy use after losing weight. It compares the medicine to a low-calorie diet or a placebo (a pill with no active ingredient) in adults with obesity.
This trial tests a combination of two medicines, alpha-lipoic acid (an antioxidant) and mirabegron (a drug for bladder issues), to see if they help people with obesity lose weight and improve metabolism. You would receive the treatment for a period of time while researchers monitor your progress.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This study tests an investigational drug called ABBV-295 to see if it helps adults with obesity or overweight who have weight-related health conditions lose weight. It may offer a new treatment option for managing weight and improving overall health.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.